Increasing a Brain Protein May Slow Alzheimer’s Disease

Alzheimer’s disease drugs increase a type of amyloid protein, according to a new study. 

Kateryna Kon/Shutterstock

For more than 30 years, the amyloid hypothesis has postulated that the accumulation of amyloid beta proteins drives Alzheimer’s disease. However, a new study challenges this theory and suggests a paradigm shift in our understanding of the disease.

AB42, a type of amyloid beta protein, which aggregates in Alzheimer’s disease, may actually prevent cognitive decline, a new study suggests.